Big Pharma

Inify’s first ultramodern laboratory on track STOCKHOLM – August 17 2022 – Inify Laboratories, a company providing fully digitalized pathology laboratory services for cancer diagnostics, listed in June 2022 on the Euronext Growth in Oslo, is on track in building its first ultramodern laboratory at Campus Solna, Sweden, next to world-leading healthcare. “We signed a five-year leasing contract for our office and laboratory facilities at Campus Solna. These will be Inify’s headquarters, housing our first laboratory as well as our Center of Excellence,” says CEO Fredrik Palm at Inify. The company expects to move into the new facility during the...

Understanding how motor proteins shape our cells Tiny motors play large roles in our cells and are targets for new therapies. Erin Matthews Understanding the busy networks inside our cells can help researchers develop new cancer treatments and prevent dangerous fungal infections. With the help of the Canadian Light Source (CLS) at the University of Saskatchewan, a research team led by John Allingham from Queen’s University and Hernando Sosa from the Albert Einstein College of Medicine has shed light on a protein that regulates the intricate microscopic networks that give cells their shape and helps ship important molecules to diverse...

Learn How to Leverage AI for Optimal Health and Wellbeing     Boston, 2022 ― AI-enabled wearables and devices are transforming healthcare and putting the power to predict future illnesses and ultimately improve outcomes in the hands of the individual users, notes biotech expert Harry Glorikian.   “All of these sensors and technologies that are coming to the forefront are actually creating the opportunity for an individual to have their own personalized dashboard … where, instead of waiting for that silent killer to sneak up on them, you can see it when it’s coming,” Glorikian said in a recent interview....

Hypertension poses major health risk for patients in middle income countries Many people diagnosed with hypertension in four of the world’s biggest middle-income countries stop treatment and most of these patients lose control of blood pressure – potentially leading to heart problems and death, a new study reveals.   Analysing patient data from China, Indonesia, Mexico, and South Africa, experts found that policies solely aimed at improving diagnosis or initiating treatment may not lead to long-term hypertension control improvements in these and similar countries.   Researchers investigating how people with hypertension move through care over time looked at adults aged...

P-Cure Prepares to Meet Market Demand by Setting Up the Largest Production Facility of Proton Therapy Systems in the World P-Cure Ltd., the provider of the most compact 360o Gantry-less Adaptive Proton Therapy System that can be installed in existing radiotherapy vaults, announced the establishment of a new production facility in Weifang, Shandong Province, China.   P-Cure 360 Degree Gantry-less Adaptive Proton Therapy System “P-Cure is the only provider of proton therapy that can effectively install the latest cancer fighting technology within the vault instead of new linac (x-ray) equipment,” says P-Cure CEO Michael Marash. TEL AVIV, Israel (PRWEB)  P-Cure...